Category: biotech

.A minority of individuals taking Ultragenyx Pharmaceutical’s Wilson condition gene treatment UX701 have actually gone over standard-of-care medicines, leading the biotech to participate a brand

.Adhering to the news of a huge layoff shot in April and a significant restructuring effort introduced earlier this month, Genentech is sending out a

.Among a yearslong medical test downtrend in the U.K., a brand new public-private alliance has emerged in attempts to revitalize the country’s pharmaceutical screening adeptness.The

.Turnstone Biologics is minimizing its headcount by 60% and also shocking its C-suite if you want to maintain the capital to its own main clinical-stage

.Transgene’s healing vaccination applicant TG4001 has actually failed a phase 2 sound tumor trial. However, while the prospect failed to strengthen progression-free survival (PFS), the

.After leaving a clinical hold many years back, Dyne Rehab has actually revealed brand new stage 1/2 information for its own Duchenne muscle dystrophy (DMD)

.Alaunos Therapies is axing an arrangement along with Precigen, giving up licensing liberties to a customized T-cell system.The licensing agreement go back to 2018 and

.In the middle of a reconstruction campaign that is actually breathed new life into hybrid universal and ingenious medicines player Teva, the firm is bending

.Terray Therapies has actually generated $120 thousand for a series B fundraise as the AI-focused biotech purposes to transform little molecule drug progression.Brand new entrepreneur

.Terns Pharmaceuticals’ choice to lose its own liver disease passions may yet settle, after the biotech uploaded period 1 information presenting among its other applicants